İçsel, CeydaYılmaz, Veysel T.Cevatemre, BuseAygün, MuhittinUlukaya, Engin2024-07-112024-07-112019-10-260949-8257https://doi.org/10.1007/s00775-019-01736-4https://link.springer.com/article/10.1007/s00775-019-01736-4https://hdl.handle.net/11452/43159A series of the structurally related platinum(II) saccharinate (sac) complexes with alkylphenylphosphines, namely cis-[Pt(sac)(2)(PPh2Me)(2)]center dot DMSO (1), cis-[Pt(sac)(2)(PPhMe2)(2)] (2), cis-[Pt(sac)(2)(PPh2Et)(2)] (3), and cis-[Pt(sac)(2)(PPhEt2)(2)]center dot 2DMSO (4), were synthesized and fully characterized; their structures were determined by X-ray crystallography. All the complexes were investigated for their anticancer potentials on three human cancer cells including A549 (lung), MCF-7 (breast), and HCT116 (colon) in addition to a noncancerous human bronchial epithelial cells (BEAS-2B). Specifically, 1 and 3 showed significant cytotoxic effects against MCF-7 and HCT116 cell lines in comparison to cisplatin, and were considered as the most potent ones in the series. The cytotoxic complexes were found to cleave DNA efficiently. In addition, the binding interactions of the complexes with DNA were confirmed by enzyme inhibition and molecular docking studies. Complexes 1 and 3 were capable of inducing apoptosis and arrested the cell cycle at the DNA synthesis (S) phase in MCF-7 cells. Furthermore, 1 and 3 caused the excessive generation of reactive oxygen species (ROS), leading to mitochondrial dysfunction and double-strand DNA breaks.eninfo:eu-repo/semantics/closedAccessAscites-carcinoma eacAntiproliferative activityPalladium(ii)CellsMitochondriaCisplatinDockingSacPdPlatinum(ii)SaccharinatePhosphineDna cleavageCytotoxicityBiochemistry & molecular biologyChemistryArticle000492655800002758725110.1007/s00775-019-01736-4